
Aarti Pharmalabs Ltd. (AARTIPHARM): Aarti Pharmalabs Share Price rises 3.73% near 52-week high
Updated: 29 Sept 2026 • 1:24 pm
Posted by:

Aarti Pharmalabs Share Price is trading at Rs 948.05, up 3.73% today, and remains close to its 52-week high as the stock moves within a narrow band of the recent range. The company’s market capitalisation stands at Rs 8,514.38 crore, placing the latest Aarti Pharmalabs Share Price update in a clear large-capitalisation context for readers tracking Aarti Pharmalabs Share Price Today and Aarti Pharmalabs Stock News. The move is visible in the day’s price action, but the latest Univest figures do not establish a company-specific catalyst. For investors searching Aarti Pharmalabs Share Price, the key question is what the latest numbers say about valuation, sector positioning and the latest Aarti Pharmalabs Share News.
As of 29 September 2026 at 1:22 PM IST, Aarti Pharmalabs Share Price opened at Rs 912 and was last traded at Rs 948.05 after moving between Rs 908.85 and Rs 951. This places Aarti Pharmalabs Share Price near its 52-week high zone while still trading below the day’s peak. The stock is also drawing attention in Aarti Pharmalabs Stock News and Aarti Pharmalabs Share Price Live searches because the latest move can be read directly from price data, market cap and valuation metrics rather than from any unstated trigger. Univest tracks the Aarti Pharmalabs Share Price movement alongside Aarti Pharmalabs NSE and Aarti Pharmalabs BSE references so readers can follow the event in one place.
Aarti Pharmalabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 948.05 |
| Previous Close | Rs 914 |
| Today's Move | +Rs 34.05 (+3.73%) |
| Open | Rs 912 |
| High | Rs 951 |
| Low | Rs 908.85 |
| Market Capitalisation | Rs 8,514.38 crore |
Aarti Pharmalabs Ltd. (AARTIPHARM) traded at Rs 948.05 versus the previous close of Rs 914, a rise of 3.73%. The stock opened at Rs 912, reached a high of Rs 951 and touched a low of Rs 908.85.
Aarti Pharmalabs Share Price Today reflects a gain of Rs 34.05 over the previous close of Rs 914, with the stock last traded at Rs 948.05. The day’s range was Rs 908.85 to Rs 951, and the opening print was Rs 912. The latest Aarti Pharmalabs Share Price action shows the stock trading above the previous session’s level while staying close to its yearly high region. Because the near-52-week-high screen is the event trigger, the stock is appearing in 52 Week High Stocks and Stock Market Today searches, and that is enough to explain why Aarti Pharmalabs Share Price News is being watched without adding an unverified catalyst. On this basis, the verified facts show a firm intraday move and a close-to-peak position, which keeps Aarti Pharmalabs Share Price Update relevant for near-term tracking.
For readers scanning Aarti Pharmalabs Share Price Today, the useful check is whether the stock continues to hold above the earlier reference points while staying near the one-year high. That is the main price-action takeaway from Aarti Pharmalabs Share Price data today. Univest presents the same price movement in a clean format for quick comparison across Aarti Pharmalabs Stock Analysis and Aarti Pharmalabs Share News pages.
Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 8,514.38 crore |
| P/E Ratio | 38.88x |
| P/B Ratio | 3.78x |
| ROE | 8.5% |
| ROCE | 10.77% |
| EPS | Rs 23.51 |
| Book Value Per Share | Rs 241.54 |
| Dividend Yield | 0.38% |
Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 38.88x, P/B 3.78x, ROE 8.5%, ROCE 10.77%. These figures provide context only and are not a buy or sell signal.
Aarti Pharmalabs Ltd. has a market capitalisation of Rs 8514.38 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.88x, P/B at 3.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.38%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.91x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.88x |
| Benchmark Median P/E | 27.91x |
| Benchmark Average P/E | 41.63x |
| Benchmark P/E Range | 0x to 707.31x |
| Company P/B Ratio | 3.78x |
| Benchmark Median P/B | 2.83x |
| Company ROE | 8.5% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 10.77% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 8,514.38 crore |
| Benchmark Median Market Cap | Rs 782.41 crore |
Aarti Pharmalabs Ltd. (AARTIPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 38.88x, which is above the benchmark median of 27.91x, a difference of +39.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.74%, a difference of -27.6%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.63%, a difference of -20.98%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Procter & Gamble Health Ltd. | PGHL | 8,972.96 | 25.14 | 14.58 | 62.18 | 84.86 |
| Supriya Lifescience Ltd. | SUPRIYA | 7,925.95 | 39.95 | 6.49 | 19.06 | 25.3 |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR | 9,159.39 | 34.43 | 26.33 | 73.2 | 98.11 |
| Suven Life Sciences Ltd. | SUVEN | 9,464.44 | 0 | 16.33 | -101.8 | -78.71 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 7,542.02 | 57.59 | 6.36 | 12.11 | 17.4 |
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 38.88x compared with the displayed peer median of 34.43x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.5% compares with a peer median of 19.06% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 25.3%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 8,514.38 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Aarti Pharmalabs
- Aarti Pharmalabs Share Price is trading at Rs 948.05, up 3.73% from the previous close.
- The stock is near its 52-week high zone after moving between Rs 908.85 and Rs 951 today.
- Market capitalisation stands at Rs 8,514.38 crore for Aarti Pharmalabs Share Price Today.
- The P/E ratio is 38.88 and the P/B ratio is 3.78, which places Aarti Pharmalabs Share Price above the industry median on both measures.
- ROE of 8.5% and ROCE of 10.77% give Aarti Pharmalabs Fundamental Analysis a lower profitability reading than the same-industry median.
About Aarti Pharmalabs
Aarti Pharmalabs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For readers following Aarti Pharmalabs Share Price, that classification is the core business context currently available in the latest Univest data. The stock is listed on NSE and BSE, and Aarti Pharmalabs Stock News is being tracked in the same industry set as other pharmaceutical names. In today’s Aarti Pharmalabs Share Price update, the company context is straightforward: it belongs to a large healthcare peer set with 198 same-industry companies used in the benchmark comparison. That makes Aarti Pharmalabs Share Price relevant for sector-level screens, peer comparison and stock news searches focused on Indian stock market coverage.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Aarti Pharmalabs Share Price in the news today?
Ans. Aarti Pharmalabs Share Price is in focus because it rose 3.73% to Rs 948.05 and stayed close to its 52-week high zone. The latest movement is visible in today’s price data and market-cap context.
What is Aarti Pharmalabs Share Price today?
Ans. Aarti Pharmalabs Share Price today is Rs 948.05. It is above the previous close of Rs 914 and trades near the recent yearly high area, which keeps the stock in near-peak territory.
How much did Aarti Pharmalabs Share Price move today?
Ans. Aarti Pharmalabs Share Price moved up by Rs 34.05, or 3.73%, from the previous close. The day’s range ran from Rs 908.85 to Rs 951, which gives a clear price-action snapshot.
What is Aarti Pharmalabs market cap?
Ans. Aarti Pharmalabs market cap stands at Rs 8,514.38 crore. That places the company in a substantial valuation bracket for its Healthcare and Pharmaceuticals & Drugs industry comparison set.
How does Aarti Pharmalabs compare on valuation?
Ans. Aarti Pharmalabs Share Price is supported by a P/E of 38.88 and P/B of 3.78. Both sit above the same-industry median, while ROE and ROCE remain below the benchmark medians.
What do Aarti Pharmalabs EPS and book value show?
Ans. Aarti Pharmalabs EPS is Rs 23.51 and book value is Rs 241.54. EPS shows earnings attributable to each share, while book value reflects the accounting net worth behind each share.
What is Aarti Pharmalabs dividend yield?
Ans. Aarti Pharmalabs dividend yield is 0.38%. It reflects the historical payout context relative to the current Aarti Pharmalabs Share Price and is useful for a basic income comparison.
How does Aarti Pharmalabs look versus its peers?
Track Aarti Pharmalabs Share Price on Univest
Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Aarti Pharmalabs Share Price on Univest for live price updates, market cap, valuation ratios, fundamental ratios, sector context, peer comparison and 52-week levels. Univest also keeps Aarti Pharmalabs Share Price Today and Aarti Pharmalabs Stock News together so the latest market update is easy to review in one place.
Recent Articles

Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026

Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026

Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026

Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





